The Iraqi Board for Medical Specializations
  • Register
  • Login

Iraqi Postgraduate Medical Journal

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 12, Issue 3
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Advisory Board

Editorial Staff

Publication Ethics

Indexing and Abstracting

News

The Effectiveness of Tramadol in Treatment of Premature Ejaculation on-Demand Basis

    Montadhar H. Nima Samir Ali Muter Ahmed Samir Al-Naaimi Nibbras I. Al-Hamdani

Iraqi Postgraduate Medical Journal, 2013, Volume 12, Issue 3, Pages 429-435

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

ABSTRACT:

*Department of Surgery, College of Medicine,
University of Baghdad.
**Department of Surgery, College of Medicine,
University of Baghdad.
***Department of Community Medicine, College
of Medicine, University of Baghdad.
****Consultant Urologist, Baghdad Medical City.



BACKGROUND:
Premature ejaculation (PE) is a worldwide problem. Selective serotonin reuptake inhibitors (SSRIs) are
widely used “off label” as pharmacotherapeutic agents in the treatment of PE.
OBJECTIVE:
Assess the efficacy of Tramadol for on-demand treatment of PE.
PATIENTS AND METHODS:
During the period December 2008 through November 2009, 60 married men visited the surgical
specialties hospital urology outpatient and consultancy clinics complaining of premature ejaculation
were enrolled in this study. Intravaginal ejaculation latency time (IVELT) was used as an objective tool
to assess the efficacy of the investigated treatment. Single-blind, placebo-controlled therapeutic trial
was conducted on 60 patients with lifelong PE. PE was defined as IVELT of <2 minutes in at least 80%
of intercourse episodes. The patients cohort was randomised into 2 equal sized groups. The intervention
group (n=30) used 50 mg tablet of Tramadol hydrochloride, while the control group (n=30) used a
placebo tablet for 8 weeks. Drugs were taken 1–2 hours before sexual activity, and sexual intercourse
was required at least once per week. IVELT was timed by a stopwatch at each intercourse.
RESULTS:
The mean IVELT after tramadol and placebo significantly increased from 73.1 and 67.9 seconds to
approximately 442.1 and 113.3 seconds, respectively (P < 0.001). Sexual satisfaction was used to assess
the cut-off values of IVELT in defining the minimal and best clinical response to treatment. There was
no withdrawal symptoms recorded following the use of tramadol or placebo, but more adverse events
were associated with tramadol treatment
CONCLUSION:
Tramadol seems to provide significantly better results in terms of IVELT and intercourse satisfaction
versus placebo. Further studies are required to draw final conclusions on the efficacy of this drug in
premature ejaculation
Keywords:
    premature ejaculation Tramadol
  • PDF
  • XML
(2013). The Effectiveness of Tramadol in Treatment of Premature Ejaculation on-Demand Basis. Iraqi Postgraduate Medical Journal, 12(3), 429-435.
Montadhar H. Nima; Samir Ali Muter; Ahmed Samir Al-Naaimi; Nibbras I. Al-Hamdani. "The Effectiveness of Tramadol in Treatment of Premature Ejaculation on-Demand Basis". Iraqi Postgraduate Medical Journal, 12, 3, 2013, 429-435.
(2013). 'The Effectiveness of Tramadol in Treatment of Premature Ejaculation on-Demand Basis', Iraqi Postgraduate Medical Journal, 12(3), pp. 429-435.
The Effectiveness of Tramadol in Treatment of Premature Ejaculation on-Demand Basis. Iraqi Postgraduate Medical Journal, 2013; 12(3): 429-435.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 192
  • PDF Download: 171
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus